Myocardial perfusion imaging with 99mTc tetrofosmin. Comparison to 201Tl imaging and coronary angiography in a phase III multicenter trial. Tetrofosmin International Trial Study Group.
about
The evaluation of cocaine-induced chest pain with acute myocardial perfusion imagingAssessment of cardiac ischaemia and viability: role of cardiovascular magnetic resonanceSuperior diagnostic performance of perfusion-cardiovascular magnetic resonance versus SPECT to detect coronary artery disease: The secondary endpoints of the multicenter multivendor MR-IMPACT II (Magnetic Resonance Imaging for Myocardial Perfusion AAre technetium-99m-labeled myocardial perfusion agents adequate for detection of myocardial viability?Role of myocardial perfusion imaging for risk stratification in suspected or known coronary artery diseaseMR-IMPACT: comparison of perfusion-cardiac magnetic resonance with single-photon emission computed tomography for the detection of coronary artery disease in a multicentre, multivendor, randomized trial.Impact of hypertension on the accuracy of exercise stress myocardial perfusion imaging for the diagnosis of coronary artery disease.Single-photon agents for tumor imaging: 201Tl, 99mTc-MIBI, and 99mTc-tetrofosmin.Long-term prognostic value of exercise technetium-99m tetrofosmin myocardial perfusion single-photon emission computed tomography.Value of thallium-201 imaging in detecting adverse cardiac events after myocardial infarction and thrombolysis: a follow up of 100 consecutive patients.The cardioprotective role of preinfarction angina as shown in outcomes of patients after first myocardial infarctionNinth annual Mario S. Verani memorial lecture : testing our tests: the evidence bar is rising. Regulatory considerations in the development of cardiac imaging agents.Future strategies in the management of coronary artery disease.Comparison of ⁹⁹mTc-N-DBODC5 and ⁹⁹mTc-MIBI of myocardial perfusion imaging for diagnosis of coronary artery disease.Myocardial viability assessment with gated SPECT Tc-99m tetrofosmin % wall thickening: comparison with F-18 FDG-PET.The state of the future is solid.Evaluation of Tc-99m tetrofosmin scan for coronary artery disease diagnosis.Incremental prognostic value of dobutamine-atropine stress 99mTc-tetrofosmin myocardial perfusion imaging for predicting outcome in diabetic patients with limited exercise capacity.Radiopharmaceutical tracers for cardiac imaging.Tolerance of MRI vs. SPECT myocardial perfusion studies--a patient survey.Resting Myocardial Contrast Echocardiography for the Evaluation of Coronary Microcirculation Dysfunction in Patients With Early Coronary Artery Disease.Advances in myocardial perfusion imaging.
P2860
Q28370530-1C16867C-0272-46E8-9E1F-81D8DA04637FQ28387402-B432D613-3F8D-4D3D-91EC-757F4C41F5F8Q30424941-4B1AB20A-4238-4099-A36B-00045A679BFEQ30472002-DCCF39AE-94E0-45B5-BF96-7CF2DBA25C19Q30542492-FC3E19E6-0A03-441E-BF83-224E3D76885FQ34738853-00BFBADD-E8AB-4226-B7AB-A9CDCB32E71AQ35379371-3E47A986-8050-4952-830F-DE7DC3BF4293Q35804149-76597463-816C-480F-B440-CA23EB11AD51Q36291507-5518CD9B-CD76-4EE0-BE21-CC049AF66384Q36606977-5656DABD-28D0-4D6B-8C26-01BAB53278F5Q37023664-6CDDBD49-24D9-47F2-964A-9387F86BE84EQ37884461-6CF51B4D-0628-48BC-85DA-BE31F7AE0FD5Q40292946-0DF35C99-6489-4A3A-AB07-542C4E80E2BCQ42125208-1B1F9D66-35FD-4DC6-A777-A695AB4B5059Q43939098-D3973E32-74B9-4F4D-B6C8-351959C5AB76Q44071832-75C02616-ABFE-47A1-B144-26BE8EBA180AQ44126916-BD3DAED6-3BF5-4EFB-B797-DF71CAFBDA58Q44379920-354CD2D2-76BF-4E00-99F9-87A91D5E358DQ49352380-1A6F5E8C-2383-43C4-84E3-FF42BAED85C3Q51003941-607EC1EE-7038-4E0E-904C-BC37F7D52EFCQ52983055-1ADD235C-D4FA-483A-8F20-030F76D9ADC7Q53184122-C4A3E85E-AA49-4694-BC84-666C262490AE
P2860
Myocardial perfusion imaging with 99mTc tetrofosmin. Comparison to 201Tl imaging and coronary angiography in a phase III multicenter trial. Tetrofosmin International Trial Study Group.
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年学术文章
@wuu
1995年学术文章
@zh-cn
1995年学术文章
@zh-hans
1995年学术文章
@zh-my
1995年学术文章
@zh-sg
1995年學術文章
@yue
1995年學術文章
@zh
1995年學術文章
@zh-hant
name
Myocardial perfusion imaging w ...... ternational Trial Study Group.
@en
Myocardial perfusion imaging w ...... ternational Trial Study Group.
@nl
type
label
Myocardial perfusion imaging w ...... ternational Trial Study Group.
@en
Myocardial perfusion imaging w ...... ternational Trial Study Group.
@nl
prefLabel
Myocardial perfusion imaging w ...... ternational Trial Study Group.
@en
Myocardial perfusion imaging w ...... ternational Trial Study Group.
@nl
P2093
P356
P1433
P1476
Myocardial perfusion imaging w ...... ternational Trial Study Group.
@en
P2093
Iskandrian AS
Serafini AN
Sridhara BS
Wackers FJ
P304
P356
10.1161/01.CIR.91.2.313
P407
P577
1995-01-01T00:00:00Z